CoChat

Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity

Open access
Weber, Elijah J., Lidberg, Kevin A., Wang, Lu, Bammler, Theo K., MacDonald, James W., Li, Mavis J., Redhair, Michelle, Atkins, William M., Tran, Cecilia, Hines, Kelly M., Herron, Josi, Xu, Libin, Monteiro, Maria Beatriz, Ramm, Susanne, Vaidya, Vishal, Vaara, Martti, Vaara, Timo, Himmelfarb, Jonathan, Kelly, Edward J. · 2018 · JCI Insight
Cited by 81

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Drug-induced kidney injury, largely caused by proximal tubular intoxicants, limits development and clinical use of new and approved drugs. Assessing preclinical nephrotoxicity relies on animal models that are frequently insensitive; thus, potentially novel techniques - including human microphysiological systems, or "organs on chips" - are proposed to accelerate drug development and predict safety. Polymyxins are potent antibiotics against multidrug-resistant microorganisms; however, clinical use remains restricted because of high risk of nephrotoxicity and limited understanding of toxicological mechanisms. To mitigate risks, structural analogs of polymyxins (NAB739 and NAB741) are currently in clinical development. Using a microphysiological system to model human kidney proximal tubule, we exposed cells to polymyxin B (PMB) and observed significant increases of injury signals, including kidney injury molecule-1 KIM-1and a panel of injury-associated miRNAs (each P < 0.001). Surprisingly, transcriptional profiling identified cholesterol biosynthesis as the primary cellular pathway induced by PMB (P = 1.22 ×10-16), and effluent cholesterol concentrations were significantly increased after exposure (P < 0.01). Additionally, we observed no upregulation of the nuclear factor (erythroid derived-2)-like 2 pathway, despite this being a common pathway upregulated in response to proximal tubule toxicants. In contrast with PMB exposure, minimal changes in gene expression, injury biomarkers, and cholesterol concentrations were observed in response to NAB739 and NAB741. Our findings demonstrate the preclinical safety of NAB739 and NAB741 and reveal cholesterol biosynthesis as a potentially novel pathway for PMB-induced injury. To our knowledge, this is the first demonstration of a human-on-chip platform used for simultaneous safety testing of new chemical entities and defining unique toxicological pathway responses of an FDA-approved molecule.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci.insight.123673

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 81

Metadata

Authors
Weber, E. J., Lidberg, K. A., Wang, L., Bammler, T. K., MacDonald, J. W., Li, M. J., Redhair, M., Atkins, W. M., Tran, C., Hines, K. M., Herron, J., Xu, L., Monteiro, M. B., Ramm, S., Vaidya, V., Vaara, M., Vaara, T., Himmelfarb, J., & Kelly, E. J.
Venue
JCI Insight
Published
2018-12-20
Volume
3
Issue
24
ISSN
2379-3708 (ISSN-L)
OpenAlex
W2905499843
Cited by
81
References
5
FWCI
5.99
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity. https://app.cochat.ai/papers/10.1172/jci.insight.123673
The paper
Weber, E. J., Lidberg, K. A., Wang, L., Bammler, T. K., MacDonald, J. W., Li, M. J., Redhair, M., Atkins, W. M., Tran, C., Hines, K. M., Herron, J., Xu, L., Monteiro, M. B., Ramm, S., Vaidya, V., Vaara, M., Vaara, T., Himmelfarb, J., & Kelly, E. J. (2018). Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity. JCI Insight. https://doi.org/10.1172/jci.insight.123673

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.